| Term 
 
        | clinical hallmarks of heart failure due to systolic dysfunction |  | Definition 
 
        | decrease in ejection fraction and stroke volume + venous congestion (pulmonary and peripheral edema) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | low cardiac output -> fatigue, tachycardia, hypotension, exercise intolerance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | venous return exceeds stroke folume -> dyspnea, pulmonary edema, right heart failure, peripheral edema |  | 
        |  | 
        
        | Term 
 
        | drugs to improve symptoms of heart failure (4 categories) |  | Definition 
 
        | decrease preload - diuretics, nitrate vasodilators decrese afterload - arteriolar vasodilator
 decrease prload and afterload via balanced vasodilation - ACEI
 increase ventricular contractility - positive inotropic agent
 |  | 
        |  | 
        
        | Term 
 
        | drugs to reverse cardiac remodeling and increase longevity |  | Definition 
 
        | blocking angII, aldo and adrenergic receptors |  | 
        |  | 
        
        | Term 
 
        | how do loop diuretics (furosemide) help CH? how do they not? |  | Definition 
 
        | decreases ECF volume, decreases venous return = preload; decreases congestive symptoms don't improve survival
 |  | 
        |  | 
        
        | Term 
 
        | drugs to decrease cardiac preload |  | Definition 
 
        | nitrate vasodilators - isosorbide mono/di-nitrate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -pril increase ejection fraction and stroke volume, decrease congestive symptoms, reverse cardiac remodling, increase longevity
 |  | 
        |  | 
        
        | Term 
 
        | Angiotensin Receptor Blockers |  | Definition 
 
        | -sartan increase ejection fraction and stroke volume, decrease congestive symptoms, reverse cardiac remodling, increase longevity
 |  | 
        |  | 
        
        | Term 
 
        | ACE inhibitors effect on venous return
 afterload
 left ventricular end diastolic volume
 RBF
 GFR
 filtration fraction
 MAP
 HR
 |  | Definition 
 
        | 1. venodilation -> decreased venous return (preload) -> LV-EDV and LV-EDP and LAP (wedge pressure) decrease 2. arteriolar dilation -> decr afterload (TPR) -> incr EF and SV -> decr LV-EDV, LV-EDP, LAP
 3. incr SV, decr LV-EDV -> decr LV wall stress -> decr pulmonary congestion
 4. RBF and GFR incr, RBF increases more -> incr FF -> diuresis
 5. MAP and HR - no change or slight decrease
 |  | 
        |  | 
        
        | Term 
 
        | another way to acheive balanced vasodilation (besides ACEIs) |  | Definition 
 
        | nitrate venodilator = isosorbide dinitrate + arterial vasodilator = hydralazine 
 incr SV, EF, exercise tolerance
 decr RV and LV filling pressure, LV EDV, V wall stress and pulm cong
 
 decr mortality, esp in blacks
 
 incr NO -> decr remodeling
 |  | 
        |  | 
        
        | Term 
 
        | drugs which decrease backward failure, reverse cardiac remodeling and increase longevity |  | Definition 
 
        | aldosterone receptor antagonists = spironolactone and eplerenone |  | 
        |  | 
        
        | Term 
 
        | spironolactone vs eplerenone |  | Definition 
 
        | S has short T1/2 and doesn't cause hyperkalemia as much E doesn't cause gynecomastia, breast pain, azoospermia, hirtuism
 |  | 
        |  | 
        
        | Term 
 
        | drugs that reverse cardiac remodeling leading to increase in EF, SV and longevity |  | Definition 
 
        | Beta Blockers "-olol" prevent remodeling of myocardium caused by excessive sympathetic stimulation
 decrease suden death by preventing bentricular dysrhythmias
 antianginal
 "start low, go slow"
 |  | 
        |  | 
        
        | Term 
 
        | drugs that decrease pulmonary congestion by increasing EF and SV and have marginal effect to increase longevity, but don't reverse cardiac remodeling |  | Definition 
 
        | digoxin - direct positive inotropic effect
 inhibits N/K ATPase (binds to phosphorylated aspartate) -> incr IC Na -> slows extrusion of Ca -> incr Ca in SR -> incr myocardial contractility
 |  | 
        |  | 
        
        | Term 
 
        | good and bad effects of digoxin (3 engineer brothers)
 |  | Definition 
 
        | good mechanical (direct) - increase myocardiac contractility good electrical (indirect) - increase vagal/ decrease SNS -> decr HR, AV conduction, automaticity, incr effective refractory period
 bad electrical (direct) - decr phase 4 membrane potential difference, incr automaticity (PACs and PVCs), AV block
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HF from systolic dysfunction refractory to ACEI and diuretics HF w/ atrial fibrillations - enhances ventricular contractility
 |  | 
        |  | 
        
        | Term 
 
        | drugs that enhance the bradycardia and decrease in AV conduction produced by digoxin: |  | Definition 
 
        | verapamil and diltiazem = Ca channel blockers beta blockers
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | "pumps fine but can't fill" if it can't relax, can't have a normal starling curve
 |  | 
        |  | 
        
        | Term 
 
        | prevention of diastolic dysfunction |  | Definition 
 
        | tx HTN to prevent LVH tx ischemia caused by CAD w/ antilipemic drugs, antianginal drugs, or CABG
 valve replacement in aortic stenosis
 |  | 
        |  | 
        
        | Term 
 
        | clinical hallmarks of HF caused by diastolic dysfunction |  | Definition 
 
        | pulmonary congestion, dyspnea, decreased exercise tolerance despite the fact that EF is >50% |  | 
        |  | 
        
        | Term 
 
        | Tx HF caused by diastolic dysfunction |  | Definition 
 
        | Relieve sx - decrease pulmonary venous pressure at rest and during exercise. Reverse LVH - increase ventricular compliance and filling
 Reverse remodeling of LV - block aldosterone receptors
 Decrease heartrate - prolong diastole - better filling
 Prevent ischemia - makes wall stiffer
 |  | 
        |  | 
        
        | Term 
 
        | Drug to decrease left ventricular diastolic pressure and pulmonary pressure |  | Definition 
 
        | Diuretics decrease blood volume
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACE inhibitor or ARB Ang II - mitogenic -> hypertrophy
 aldo - stimulates collagen synthesis and deposition
 |  | 
        |  | 
        
        | Term 
 
        | Drug to prolong diastolic filling |  | Definition 
 
        | Beta blockers - reduce heartrate |  | 
        |  | 
        
        | Term 
 
        | Digoxin for tx of diastolic heart failure |  | Definition 
 
        | DONT DO IT digoxin decreae HR via central effect to increase efferent vagal nerve activity, but it's difficult to titrate and causes toxicity
 |  | 
        |  | 
        
        | Term 
 
        | Which patients get ACE inhibitors or ARBs? |  | Definition 
 
        | everyone with heart failure |  | 
        |  | 
        
        | Term 
 
        | Which patients get furosemide |  | Definition 
 
        | pts w/ systolic dysfunction; use with care in pts w/ diastolic dysfunction |  | 
        |  | 
        
        | Term 
 
        | symptoms of cardiogenic shock |  | Definition 
 
        | hypotension tachycardia with a thread ulse
 tissue hypoperfusion - cold, clamy skin, decreased urine output, altered mental state
 pulmonary edema
 tx w/ NE, DA, dobutamine
 |  | 
        |  |